Clinical Trials (PDQ®) - National Cancer Institute

Page Options

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp online chat

	NCI Highlights


	Maintenance Rituximab for Follicular Lymphoma Azacitidine Improves Survival in MDS Second Stem Cell Transplant Not Helpful in Myeloma

Efficacy and Safety Study of ZOMETA® in Treatment of High-Level NTX Non Small Cell Lung Cancer With Bone Metastasis

Basic Trial Information
Trial Description
Summary
Eligibility Criteria
Trial Contact Information

Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs
Phase IV Treatment Active Over 18 Other CZOL446ECN06T
NCT00762346

Trial Description

Summary

A multicenter prospective study to assess the efficacy and safety of ZOMETA® in treatment of high-level NTX non small cell lung cancer with bone metastasis.

Eligibility Criteria

Inclusion Criteria:

Age > 18

Histologically confirmed non-small cell cancer

One bone metastasis at least confirmed by imageology

NTX > 50nM BCE/mM creatinine

Life expectancy > 6 M

ECOG <= 2

Signed ICF

Exclusion Criteria:

Women who are pregnant or in lactation

Patients with hyperostosis with brain metastasis(exception of those without symptom or with Metastasis Lesions under controlled

Previous or current treatment with any other bisphosphonates, bone- protecting, cytotoxic or targeted therapy

Severe co-morbidity of any type that may interfere with assessment of the patient for the study -

Trial Contact Information

Trial Lead Organizations/Sponsors

Sun Yat-Sen University First Hospital

Novartis Pharmaceuticals Corporation

Li Zhang, MD

Principal Investigator

Li Zhang, MD		Ph: 86-20-8734-3366
		Email: zhangli6@mail.sysu.edu.cn

Trial Sites

China

Guangzhou

Sun Yat-Sen University Cancer Center

Li Zhang, MD Ph: 86-20-87343366

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00762346
Information obtained from ClinicalTrials.gov on March 18, 2009

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.